title: Successful stem cell transplant with antibody-based conditioning for XIAP deficiency with refractory hemophagocytic lymphohistiocytosis.
authors.forename: Austen J J
authors.initials: AJ
authors.lastname: Worth
authors.forename: Olga
authors.initials: O
authors.lastname: Nikolajeva
authors.forename: Robert
authors.initials: R
authors.lastname: Chiesa
authors.forename: Kanchan
authors.initials: K
authors.lastname: Rao
authors.forename: Paul
authors.initials: P
authors.lastname: Veys
authors.forename: Persis J
authors.initials: PJ
authors.lastname: Amrolia
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002675:Child, Preschool; D040181:Genetic Diseases, X-Linked / Q000150:complications / Q000235:genetics / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D051359:Lymphohistiocytosis, Hemophagocytic / Q000150:complications / Q000235:genetics / Q000628:therapy*; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000235:genetics / Q000628:therapy*; D008297:Male; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D061349:Unrelated Donors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000074323:Alemtuzumab